• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[无出血风险的血液透析。用于精确肝素监测的活化部分凝血活酶时间(APTT)床边检测方法的介绍——综述]

[Hemodialysis without risk of hemorrhage. Introduction of an APTT bedside method for exact heparin monitoring--a review].

作者信息

Vogel G E

出版信息

Fortschr Med. 1977 Oct 27;95(40):2437-44.

PMID:924326
Abstract

A summarized account of our experiences over 1 1/2 years is given, in relation to a minimum heparinisation technique during haemodialysis. This novel technique was made possible by the introduction of an APTT bedside method. In a comparison between the techniques employed so far for preventing a heparin-caused risk of haemorrhage and our method, the clear advantage of our method was apparent. In addition to a discussion of our methods, we describe the cases treated so far. The amounts of heparin required for dialysis are so small that a necessary coagulation can occur even in a part of the organism where there is a danger of haemorrhage. Thereby it was possible to extend the range of indication for haemodialysis substantially. By using minimum heparinisation, it is possible to perform an immediate postoperative haemodialysis. The healing of wounds, which is impaired in cases of renal insufficiency, may be improved by early dialysis without the risk of haemorrhage. Our results show that the minimum heparinisation signifies a decisive achievement in acute dialysis therapy.

摘要

本文给出了我们在一年半时间里有关血液透析期间最小肝素化技术的经验总结。这种新技术因引入了床边活化部分凝血活酶时间(APTT)检测方法而成为可能。在比较目前用于预防肝素引起的出血风险的技术与我们的方法时,我们方法的明显优势显而易见。除了讨论我们的方法外,我们还描述了迄今为止治疗的病例。透析所需的肝素量非常少,以至于即使在存在出血风险的机体部分也可能发生必要的凝血。由此,大幅扩大了血液透析的适应证范围。通过使用最小肝素化,可以在术后立即进行血液透析。早期透析可改善肾功能不全患者受损的伤口愈合,且无出血风险。我们的结果表明,最小肝素化是急性透析治疗的一项决定性成果。

相似文献

1
[Hemodialysis without risk of hemorrhage. Introduction of an APTT bedside method for exact heparin monitoring--a review].[无出血风险的血液透析。用于精确肝素监测的活化部分凝血活酶时间(APTT)床边检测方法的介绍——综述]
Fortschr Med. 1977 Oct 27;95(40):2437-44.
2
[Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].[低分子肝素预防血液透析体外循环血栓形成:具有更佳出血风险/有效性比的剂量标准化]
Acta Med Port. 1992 Feb;5(2):65-70.
3
[Control of the heparin induced bleeding risk in haemodialysis patients (author's transl)].血液透析患者肝素诱导出血风险的控制(作者译)
Med Klin. 1976 Jan 16;71(3):116-9.
4
[Theoretical basis and practical carrying out of an APTT control test for exact heparin monitoring (author's transl)].用于精确监测肝素的活化部分凝血活酶时间(APTT)对照试验的理论基础与实际开展(作者译)
Med Klin. 1977 Feb 11;72(6):207-11.
5
[Heparin dosage in chronic hemodialysis (author's transl)].慢性血液透析中的肝素剂量(作者译)
Med Klin. 1977 Oct 7;72(40):1617-23.
6
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.间歇性血液透析期间四种低剂量抗凝模式的评估
Eur J Clin Pharmacol. 2018 Mar;74(3):267-274. doi: 10.1007/s00228-017-2389-x. Epub 2017 Dec 2.
7
[Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].[CY 216(速碧林)静脉推注给药在有或无出血风险的急慢性肾功能不全患者血液透析和血液滤过中的应用]
Nephrologie. 1990;11(1):17-21.
8
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.使用抗Xa因子特异性全血凝血测定法监测血液透析中的肝素。
Nephrol Dial Transplant. 1995;10(2):217-22.
9
[Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].[血液透析中抗凝的动力学。单次、间歇性和持续性肝素化的序贯研究]
Minerva Med. 1980 Oct 27;71(41):2987-91.
10
Clinical consequences of heparin-free hemodialysis.无肝素血液透析的临床后果
Hemodial Int. 2005 Oct;9(4):393-8. doi: 10.1111/j.1542-4758.2005.01158.x.